Bionomics Ltd BNOX

Healthcare Biotechnology

Bionomics Ltd is an Australia-based clinical-stage biopharmaceutical company. The Company is focused on development of novel drug candidates focused on the treatment of serious central nervous system disorders. It is developing novel allosteric ion channel modulators to treat patients suffering from serious central nervous system (CNS) disorders with high unmet medical need. It is advancing its lead drug candidate, BNC210, an oral, proprietary, selective negative allosteric modulator of the a7 nicotinic acetylcholine receptor, for the acute treatment of social anxiety disorder (SAD) and chronic treatment of post-traumatic stress disorder (PTSD). Its a7 Receptor Positive Allosteric Modulators (PAMs) pipeline is targeting cognitive dysfunction associated with Alzheimer’s disease and other central nervous system conditions. The Company’s CNS pipeline also includes preclinical assets that target Kv3.1/3.2 and Nav1.7/1.8 ion channels.

NDAQ:BNOX - Post by User

Bionomics Ltd

<< Previous

Bullboard Posts

Post by coolfooldumbguyon Jul 18, 2024 10:55am

67 Views

Post# 36138366

This stock is still cheap.

Bought 20000 shares of this Aussie biotech company,off of its multi-year low of .65cents,my price was .83 cents/share,but you should do your own due diligence of course,and as always, so gets shareholders.

<< Previous

Bullboard Posts

Rig Count Soars as Utilization Surpasses Industry Averages